Palatin Technologies Inc (0KF3.L)

Healthcare | Medical Pharmaceuticals
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 0 0 0 350,000
Cost of Revenue 0 162,309 169,988 -517,947
Gross Profit 0 -162,309 -169,988 867,947
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,474,019 1,681,844 2,020,931 4,003,779
Operating Expenses 4,813,177 2,611,323 7,764,685 8,692,071
Operating Income -4,813,177 -2,611,323 -7,764,685 -8,342,071
Interest Expense 1,795 3,803 5,940 3,373
Income Before Tax -4,811,420 -2,442,482 -7,823,649 -8,250,430
Income Tax Expense 0 0 0 0
Net Income -4,811,420 -2,442,482 -7,823,649 -8,250,430
Per Share
EPS -0.18 -0.12 -0.39 -0.56
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30
Revenue 0 4,490,090 4,853,678
Cost of Revenue 0 97,637 418,470
Gross Profit 0 4,392,453 3,775,538
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 7,809,345 12,270,046 15,290,836
Operating Expenses 22,707,839 26,888,574 36,894,091
Operating Income -17,459,939 -22,496,121 -32,458,883
Interest Expense 15,025 17,114 20,013
Income Before Tax -17,307,349 -29,736,113 -28,711,740
Income Tax Expense 0 0 -4,674,999
Net Income -17,307,349 -29,736,113 -24,036,741
Per Share
EPS -32.15 -2.02 -2.21
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30
Assets
Cash and Cash Equivalents 2,564,265 9,527,396 7,989,582
Short Term Investments 0 0 2,992,890
Net Receivables 29,468 0 2,915,760
Inventory 0 0 526,000
Total Current Assets 2,919,428 9,769,668 16,321,513
Property Plant Equipment 290,610 915,682 1,561,011
Goodwill and Intangibles 0 0 0
Total Assets 3,266,954 10,742,266 17,939,440
Liabilities
Account Payables 6,998,806 4,101,929 4,303,527
Short Term Debt 129,812 426,556 920,888
Total Current Liabilities 8,010,030 9,657,681 15,131,830
Long Term Debt 33,969 163,782 590,337
Total Liabilities 8,043,999 10,853,763 17,805,367
Shareholders Equity
Retained Earnings -459,073,899 -441,766,550 -415,535,583
Total Shareholders Equity -4,777,045 -111,497 134,073
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30
Assets
Cash and Cash Equivalents 2,564,265 9,527,396 7,989,582
Short Term Investments 0 0 2,992,890
Net Receivables 29,468 0 2,915,760
Inventory 0 0 526,000
Total Current Assets 2,919,428 9,769,668 16,321,513
Property Plant Equipment 290,610 915,682 1,561,011
Goodwill and Intangibles 0 0 0
Total Assets 3,266,954 10,742,266 17,939,440
Liabilities
Account Payables 6,998,806 4,101,929 4,303,527
Short Term Debt 129,812 426,556 920,888
Total Current Liabilities 8,010,030 9,657,681 15,131,830
Long Term Debt 33,969 163,782 590,337
Total Liabilities 8,043,999 10,853,763 17,805,367
Shareholders Equity
Retained Earnings -459,073,899 -441,766,550 -415,535,583
Total Shareholders Equity -4,777,045 -111,497 134,073
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30
Operating Activities
Net Income -17,307,349 -29,736,113 -27,541,887
Depreciation & Amortization 258,917 339,075 288,331
Stock Based Compensation 1,382,281 1,872,698 1,410,917
Change in Working Capital 0 -3,406,846 392,272
Operating Cash Flow -21,306,637 -31,461,441 -28,419,000
Investing Activities
Capital Expenditure 0 -42,526 -433,927
Investments 0 -42,526 -433,927
Investing Cash Flow 3,130,000 12,450,364 -3,426,817
Financing Activities
Debt Repayment 0 -106,392 -100,922
Common Stock Issued/Repurchased 7,960,765 14,666,042 10,143,152
Dividends Paid 0 0 0
Financing Cash Flow 11,213,506 20,548,891 9,896,246
Summary
Free Cash Flow -21,306,637 -31,503,967 -28,852,928
Net Change in Cash -6,963,131 1,537,814 -21,949,572
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30
Operating Activities
Net Income -17,307,349 -29,736,113 -27,541,887
Depreciation & Amortization 258,917 339,075 288,331
Stock Based Compensation 1,382,281 1,872,698 1,410,917
Change in Working Capital 0 -3,406,846 392,272
Operating Cash Flow -21,306,637 -31,461,441 -28,419,000
Investing Activities
Capital Expenditure 0 -42,526 -433,927
Investments 0 -42,526 -433,927
Investing Cash Flow 3,130,000 12,450,364 -3,426,817
Financing Activities
Debt Repayment 0 -106,392 -100,922
Common Stock Issued/Repurchased 7,960,765 14,666,042 10,143,152
Dividends Paid 0 0 0
Financing Cash Flow 11,213,506 20,548,891 9,896,246
Summary
Free Cash Flow -21,306,637 -31,503,967 -28,852,928
Net Change in Cash -6,963,131 1,537,814 -21,949,572